Search Results - "Blanset, D"
-
1
A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo
Published in Leukemia (01-08-2017)“…B-cell maturation antigen (BCMA) is a highly plasma cell-selective protein that is expressed on malignant plasma cells of multiple myeloma (MM) patients and…”
Get full text
Journal Article -
2
A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo
Published in Leukemia (01-10-2017)“…This corrects the article DOI: 10.1038/leu.2016.388…”
Get full text
Journal Article -
3
WS17.06 F/HN pseudotyped lentiviral vector-mediated transduction of non-human primates
Published in Journal of cystic fibrosis (01-06-2023)Get full text
Journal Article -
4
Erratum: A novel BCMA/CD3 bispecific T-cell engager for the treatment of multiple myeloma induces selective lysis in vitro and in vivo
Published in Leukemia (01-10-2017)“…Correction to: Leukemia advance online publication 13 January 2017; doi:10.1038/leu.2016.388 Following the publication of this article, it was noted that the…”
Get full text
Journal Article -
5
CTLA-4 blockade decreases TGF-β, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques
Published in Blood (01-12-2006)“…Regulatory T (Treg) cells are a subset of CD25+CD4+ T cells that constitutively express high levels of cytotoxic T lymphocyte antigen-4 (CTLA-4) and suppress…”
Get full text
Journal Article -
6
Anagrelide metabolite induces thrombocytopenia in mice by inhibiting megakaryocyte maturation without inducing platelet aggregation
Published in Experimental hematology (01-12-2001)“…The mechanism for anagrelide's potent platelet lowering activity in human subjects is not well defined. Studies related to anagrelide function have been…”
Get full text
Journal Article -
7
Activity and Safety of CTLA-4 Blockade Combined with Vaccines in Cynomolgus Macaques
Published in The Journal of immunology (1950) (01-12-2003)“…The immune modulatory molecule CTLA-4 (CD152), through interactions with the B7 costimulatory molecules, has been shown to be a negative regulator of T cell…”
Get full text
Journal Article